Abbvie Inc at Wolfe Research Healthcare Conference (Virtual) Transcript
Okay. Great. Thanks for joining us. I'm Tim Anderson, the large cap pharma and biotech analyst at Wolfe Research, and for the next half an hour, we'll be talking with 3 members of AbbVie's management team.
Rick Gonzalez, who's the CEO and Chairman of the Board. He spent more than 30 years at Abbott and went to AbbVie after it split out. And he's worked, of course, in a variety of roles, commercial, R&D and manufacturing.
We have Mike Severino, who's Vice Chairman and President of AbbVie, responsible for R&D and other expanded roles within the organization. He joined the company in 2014. Prior to that, he was at Amgen and Merck.
And we have Rob Michael, who's EVP and CFO of AbbVie. Prior to that, he held a variety of roles within AbbVie and the predecessor company, Abbott, and he joined Abbott in 1993. So we're just going to jump straight into Q&A, given the limited amount of time.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |